The treatment of invasive fungal infections has deeply evolved in the last years with the inclusion of new antifungals, mainly new azoles (i.e., posaconazole, isavuconazole), to the therapeutic armamentarium. This review focuses on the role of isavuconazole for treating the most important invasive fungal infections both in animals and humans (hematological and non-hematological patients).
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7712195 | PMC |
| http://dx.doi.org/10.3390/jof6040209 | DOI Listing |
Publication Analysis
Top Keywords
invasive fungal
8
fungal infections
8
isavuconazole-animal data
4
data clinical
4
clinical data
4
data treatment
4
treatment invasive
4
infections deeply
4
deeply evolved
4
evolved years
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!